Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
To evaluate the pharmacokinetic interactions of AD-2321, AD-2322 in healthy adult volunteers.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Arm A | Experimental | Period 1 : Treatment A(AD-2321), Period 2 : Treatment C(AD-2321+AD-2322) |
|
| Arm B | Experimental | Period 1 : Treatment B(AD-2322), Period 2 : Treatment C(AD-2321+AD-2322) |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Treatment A(AD-2321) | Drug | AD-2321 Oral Tablet |
| |
| Treatment B(AD-2322) |
| Measure | Description | Time Frame |
|---|---|---|
| Area under the plasma concentration-time curve during dosing interval at steady state (AUCÏ„,ss) | AUCÏ„,ss | pre-dose (0hour) to 24 hours post-dose on Day 14 |
| Maximum concentration of drug in plasma at steady state (Cmax,ss) | pre-dose (0hour) to 24 hours post-dose on Day 14 |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| SoonKeun Kwon | Contact | +82318916915 | skkwon@addpharma.co.kr |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| H+ Yangji Hospital | Seoul | South Korea |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D006973 | Hypertension |
| ID | Term |
|---|---|
| D014652 | Vascular Diseases |
| D002318 | Cardiovascular Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Drug |
AD-2322 Oral Tablet |
|
| Treatment C(AD-2321+AD-2322) | Drug | AD-2321 Oral Tablet+AD-2322 Oral Tablet |
|